Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2018

Oct 15, 2018

SELL
$11.6 - $16.54 $139,200 - $198,480
-12,000 Closed
0 $0
Q2 2018

Jul 09, 2018

BUY
$13.13 - $17.09 $157,560 - $205,080
12,000 New
12,000 $2,000
Q1 2018

May 01, 2018

SELL
$13.76 - $17.12 $254,560 - $316,720
-18,500 Closed
0 $0
Q4 2017

Feb 06, 2018

BUY
$12.51 - $16.24 $231,435 - $300,440
18,500
18,500 $26,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.39B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Center Star Asset Management, LLC Portfolio

Follow Center Star Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Center Star Asset Management, LLC with notifications on news.